Bausch Health Companies Inc., headquartered in Laval, Canada, is a global player in the healthcare sector, focusing on specialty pharmaceuticals and medical devices. With a broad portfolio, the company targets key areas such as gastroenterology, neurology, dermatology, eye health, and more. It operates through distinct segments including Salix for gastroenterology products, International for a mix of devices and pharmaceuticals, Solta Medical for aesthetic devices, Diversified for a variety of therapeutic areas, and Bausch + Lomb for vision care and surgical products. Originally known as Valeant Pharmaceuticals, it rebranded in 2018 to better reflect its mission and scope.
Insiders continue to scoop up Under Armour and W.R. Berkley shares, and a public offering of International Tower Hill Mines shares prompted huge insider purchases as well.
Dan Loeb of Third Point is a brilliant investor worth watching closely whenever the 13F filings roll in. He’s a billionaire activist investor who seems to know how to spot value in…
One insider scooped up many shares as Carl Icahn exited his stake in a medical device maker. There were other notable insider purchases too.
One of the best ways to spot a potential opportunity is by tracking insiders. After all, who knows the company better than an insider – the CEO, CFO, COO, officers, employees, and…
In the past week, a couple of gold-mining stocks attracted the attention of insider buyers. Billionaire hedge fund manager John Paulson was a huge insider buyer this past week.
The best investment billionaire John Paulson ever made was a bet against something. He famously predicted the collapse of the U.S. housing market and made a $20 billion profit doing so. Today,…
